Contradicting the results of the findings of a recent study that claimed that the screening in the prostate cancer reduced the number of deaths to half in men, a new research has accentuated that there are no significant improvements made by prostate screening in its patients.

The research that took place over the period of 20 years had recruited some 1,500 men and screened them on the regular basis.

The screening techniques included digital rectal examination and prostate specific antigen testing.

It was then claimed by the report that there are no proven significant differences in the death rates of the people who underwent the screening and those who were left behind.

The Programmes Director of the UK National Screening Committee, Dr. Anne Mackie, stated: "This evidence provides further support for the recommendation the Committee made in November not to screen for prostate cancer at this time".

He further added that the negative aspects of the screening easily outshine the benefits it carries under its belt. He, however, maintained that keeping in view the demand for the screening, a re-evaluation of its importance will be done again after three years.

The findings of the study have also indicated that the 15% of the adults with normal prostate specific antigen (PSA) levels run the risk of acquiring prostate cancer in the near future.